Sensus

-$0.22 (-3.04%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Sensus and other ETFs, options, and stocks.

About SRTS

Sensus Healthcare, Inc. operates as a medical device company, which provides treatments for both oncological and non-oncological skin conditions. The firm's portfolio of treatment devices includes the SRT-100, SRT-100+, and SRT-100 Vision.

CEO

Joseph C. Sardano

Employees

Headquarters

Boca Raton, Florida

Founded

2010

SRTS Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

201.85K

High today

$7.36

Low today

$6.96

Open price

$7.24

Volume

86.36K

52 Week high

$9.04

52 Week low

$3.08

SRTS News

Simply Wall StJan 24

Recent 16% pullback isn't enough to hurt long-term Sensus Healthcare shareholders, they're still up 95% over 1 year

The Sensus Healthcare, Inc. ( ) share price has had a bad week, falling 16%. While that might be a setback, it doesn't negate the nice returns received over the

Analyst ratings

Buy

100%

Hold

Sell

SRTS Earnings

-$0.18

-$0.11

-$0.05

$0.02

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Available Feb 10, After Hours

Why Robinhood?

Sensus Healthcare, Inc. operates as a medical device company, which provides treatments for both oncological and non-oncological skin conditions. The firm's portfolio of treatment devices includes the SRT-100, SRT-100+, and SRT-100 Vision. View more

Recent 16% pullback isn't enough to hurt long-term Sensus Healthcare shareholders, they're still up 95% over 1 year

100%

Sensus Healthcare, Inc. operates as a medical device company, which provides treatments for both oncological and non-oncological skin conditions. The firm's portfolio of treatment devices includes the SRT-100, SRT-100+, and SRT-100 Vision.